China Regenerative Medicine International Limited (HKG:8158)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.3000
-0.0200 (-6.25%)
Apr 2, 2026, 3:16 PM HKT

HKG:8158 Income Statement

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
72.0690.6269.4941.54282.9
Revenue Growth (YoY)
-20.48%30.41%67.29%-85.32%55.32%
Cost of Revenue
30.1432.9650.063.91215.17
Gross Profit
41.9257.6519.4237.6267.73
Selling, General & Admin
42.3651.5245.5425.8247.45
Operating Expenses
43.5151.5245.5425.826.09
Operating Income
-1.596.14-26.1111.8161.63
Interest Expense
-1.2-1.13-0.98-0.78-0.74
Interest & Investment Income
-17.580.0100.01
Other Non Operating Income (Expenses)
17.99-4.87-80.66-3.67-1.67
EBT Excluding Unusual Items
15.1917.72-107.747.3559.24
Other Unusual Items
-0.040.040.915.05
Pretax Income
15.1917.75-107.78.2764.29
Income Tax Expense
-12.34--3.7112.47
Earnings From Continuing Operations
27.5317.75-107.74.5651.83
Net Income to Company
27.5317.75-107.74.5651.83
Net Income
27.5317.75-107.74.5651.83
Net Income to Common
27.5317.75-107.74.5651.83
Net Income Growth
55.05%---91.21%-
Shares Outstanding (Basic)
304304286285285
Shares Outstanding (Diluted)
304304286285285
Shares Change (YoY)
-6.23%0.34%-77.64%
EPS (Basic)
0.090.06-0.380.020.18
EPS (Diluted)
0.090.06-0.380.020.18
EPS Growth
55.17%---91.21%-
Free Cash Flow
-17.6810.52-15.03-3.83
Free Cash Flow Per Share
-0.060.04-0.05-0.01
Gross Margin
58.17%63.62%27.95%90.58%23.94%
Operating Margin
-2.21%6.77%-37.58%28.42%21.79%
Profit Margin
38.20%19.59%-154.99%10.97%18.32%
Free Cash Flow Margin
-19.51%15.13%-36.17%-1.35%
EBITDA
-0.936.8-25.5411.9861.71
EBITDA Margin
-1.29%7.50%-36.75%28.83%21.81%
D&A For EBITDA
0.660.660.570.170.08
EBIT
-1.596.14-26.1111.8161.63
EBIT Margin
-2.21%6.77%-37.58%28.42%21.79%
Effective Tax Rate
---44.90%19.39%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.